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Introduction
Telemedicine provides better access to users in addition to
reducing the waiting time between diagnosis in primary care
and hospital 1,2.
Telemedicine was first introduced in the Catalonian central
region as a teledermatology pilot project in Manresa in summer
2010. The waiting list in dermatology had been soaring in
primary care due to the economic context of generalized cuts in
healthcare spending and a quick solution was needed. In 2014
we published a study evaluating the impact of teledermatology
in decreasing the waiting list in the Bages region during the
period 2009-2012 and we found that due to teledermatology,
the waiting times in the dermatology services decreased from a
median of 30 days before the implementation of
teledermatology to a median of 16 days (confidence interval
95%) after its implementation 3.
Inspired by the good results of teledermatology, in November
2012 Teleulcers was introduced in the counties of Bages and
Berguedà. Teleulcers is a project aiming to improve the care of
patient with chronic wounds. Expert vascular advice is available
for primary care nurses. Three main features define this service:
its transversality, a virtual teleconsultation system and the
nursing leadership in the care of patients with chronic wounds4.
• To assess the economic impact of the telemedicine services
in the Catalonian central region.
• To assess the qualitative impact of the telemedicine services
among users and health professionals of the Catalonian
central region.
Hypothesis
This study aims to demonstrate that telemedicine services in
the Catalonian central region are efficient from the economic
point of view and enjoy acceptance among users and health
professionals
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The thesis would follow two methodological lines in order to
assess the qualitative and quantitative impact of
teledermatology and teleulcers:
• Firstly it will look the quantitative impact of the
teledermatology service through an economic analysis
comparing the teledermatology service with a conventional
dermatology service.
• Secondly, it will measure the degree of satisfaction of users
and health professionals with the teleulcers service through
structured qualitative interviews.
To ensure confidentiality, all data will be collected and
processed anonymized at all times. Data extraction will be
conducted from databases available to the information system
department of the Institut Català de la Salut and never by
directly accessing the medical records of patients.
The ethical principles of the Helsinki Declaration of 1964 as
revised by the World Health Organization in 2000 in Edinburgh
will be followed at all times. The Spanish Organic Law 15/1999
of data protection will be met.
This proposal will be submitted to the The IDIAP Jordi Gol
Clinical Research Ethics Committee.
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